NCT05127252 Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive
| NCT ID | NCT05127252 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Pregnancy Complications |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-04-10 |
| Primary Completion | 2026-03-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2023-04-10 with a primary completion date of 2026-03-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the microbiome of women with previously proven fertility who plan to become pregnant.
Eligibility Criteria
Inclusion Criteria: * Women with a previous live birth in the past 5 years and planning a new pregnancy with the same male partner. * 18-40 years of age * Swedish personal identity number and a Swedish address (to send a sampling self-kit) * Sufficient understanding of spoken and written Swedish or English to provide informed consent and complete the web-based questionnaire. Exclusion Criteria: * Women who do not have a child yet and plan to cease their contraception.
Contact & Investigator
Lars Holmgren, Professor
STUDY CHAIR
Karolinska Institutet
Frequently Asked Questions
Who can join the NCT05127252 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Pregnancy Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05127252 currently recruiting?
Yes, NCT05127252 is actively recruiting participants. Contact the research team at lars.holmgren@ki.se for enrollment information.
Where is the NCT05127252 trial being conducted?
This trial is being conducted at Stockholm, Sweden, Uppsala, Sweden.
Who is sponsoring the NCT05127252 clinical trial?
NCT05127252 is sponsored by Karolinska Institutet. The principal investigator is Lars Holmgren, Professor at Karolinska Institutet. The trial plans to enroll 500 participants.